Karyopharm Therapeutics reported $153.26M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Abbvie ABBV:US $ 6098M 3648M
Amgen AMGN:US $ 6528M 1461M
Astrazeneca AZN:US $ 5762M 567M
AstraZeneca AZN:LN 5762M 567M
Avrobio Inc AVRO:US $ 161.66M 27.9M
Biocryst Pharmaceuticals BCRX:US $ 395.5M 108.88M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Enanta Pharmaceuticals ENTA:US $ 40.99M 58.08M
Epizyme EPZM:US $ 77.42M 20.92M
GlaxoSmithKline GSK:LN 10967M 6693M
Johnson & Johnson JNJ:US $ 1579M 322M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Macrogenics MGNX:US $ 47.33M 76.14M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Novartis NVS:US $ 13852M 1445M
Novartis NOVN:VX SF 13852M 1445M
Pfizer PFE:US $ 2470M 526M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Takeda 4502:JP Y 849695M 125354M
Tg Therapeutics TGTX:US $ 185.68M 113.21M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Xencor XNCR:US $ 78.27M 65.21M
YTE INCY:US $ 2256.76M 199.32M